Article PDF
Avoid common mistakes on your manuscript.
References
Baulcombe, D. (2002). RNA silencing. Curr Biol 12, R82–R84.
Bergelson, J.M., Cunningham, J.A., Droguett, G., Kurt-Jones, E.A., Krithivas, A., Hong, J.S., Horwitz, M.S., Crowell, R.L., and Finberg, R.W. (1997). Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 275, 1320–1323.
Cetta, F., and Michels, V.V. (1995). The autoimmune basis of dilated cardiomyopathy. Ann Med 27, 169–173.
Elbashir, S.M., Harborth, J., Lendeckel, W., Yalcin, A., Weber, K., and Tuschl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411, 494–498.
Dorsett, Y., and Tuschl, T. (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat Rev Drug Discov 3, 318–329.
Fields, B.N., Knipe, D.M., Howley, P.M., and Griffin, D.E. (2001). Fields virology, 4th ed., vol. 1. Philadelphia, Pa: Lippincott Williams & Wilkins.
Fire, A., Xu, S., Montgomery, M.K., Kostas, S.A., Driver, S.E., and Mello, C.C. (1998). Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 391, 806–811.
Grist, N.R., and Reid, D. (1993). Epidemiology of viral infections of the heart. In: Viral infections of the heart. Banatvala J. E. ed. London, England: Edward Arnold, 23–31.
Henke, A., Jarasch, N., and Wutzler, P. (2003). Vaccination procedures against Coxsackievirus-induced heart disease. Expert Rev Vaccines 2, 805–815.
Kandolf, R. (1993). Molecular biology of viral heart disease. Herz 18, 238–244.
Klump, W.M., Bergmann, I., Müller, B.C., Ameis, D., and Kandolf, R. (1990). Complete nucleotide sequence of infectious Coxsackievirus B3 cDNA: two initial 5′ uridine residues are regained during plus-strand RNA synthesis. J Virol 64, 1573–1583.
Liu, Z., Carthy, C.M., Cheung, P., Bohunek, L., Wilson, J.E., McManus, B.M., and Yang, D. (1999). Structural and functional analysis of the 5′ untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. Virology 265, 206–217.
Martino, T.A., Liu, P., and Sole, M.J. (1994). Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res 74, 182–188.
Merl, S., Michaelis, C., Jaschke, B., Vorpahl, M., Seidl, S., and Wessely, R. (2005). Targeting 2A protease by RNA interference attenuates coxsackieviral cytopathogenicity and promotes survival in highly susceptible mice. Circulation 111, 1583–1592.
Racchi, G., Klingel, K., Kandolf, R., and Grassi, G. (2009). Targeting of protease 2A genome by single and multiple siRNAs as a strategy to impair CVB3 life cycle in permissive HeLa cells. Methods Find Exp Clin Pharmacol 31, 63–70.
Reyes, M.P., and Lerner, A.M. (1985). Coxsackievirus myocarditis-with special reference to acute and chronic effects. Prog Cardiovasc Dis 27, 373–394.
Rose, N.R., Herskowitz, A., and Neumann, D.A. (1993). Autoimmunity in myocarditis: models and mechanisms. Clin Immunol Immunopathol 68, 95–99.
Vaucheret, H., Béclin, C., and Fagard, M. (2001). Post-transcriptional gene silencing in plants. J Cell Sci 114, 3083–3091.
Woodruff, J.F. (1980). Viral myocarditis. A review. Am J Pathol 101, 425–484.
Yang, D., Wilson, J.E., Anderson, D.R., Bohunek, L., Cordeiro, C., Kandolf, R., and McManus, B.M. (1997). In vitro mutational and inhibitory analysis of the cis-acting translational elements within the 5′ untranslated region of coxsackievirus B3: potential targets for antiviral action of antisense oligomers. Virology 228, 63–73.
Ye, X., Liu, Z., Hemida, M.G., and Yang, D. (2011). Targeted delivery of mutant tolerant anti-coxsackievirus artificial microRNAs using folate conjugated bacteriophage Phi29 pRNA. PLoS One 6, e21215.
Yuan, J., Cheung, P.K., Zhang, H.M., Chau, D., and Yang, D. (2005). Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J Virol 79, 2151–2159.
Zhang, H.M., Su, Y., Guo, S., Yuan, J., Lim, T., Liu, J., Guo, P., and Yang, D. (2009). Targeted delivery of anti-coxsackievirus siRNAs using ligand-conjugated packaging RNAs. Antiviral Res 83, 307–316.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gautam, A. Progress in targeted delivery of siRNA to combat Coxsackievirus. Protein Cell 2, 855–857 (2011). https://doi.org/10.1007/s13238-011-1124-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13238-011-1124-0